Haleon (Centrum) Under the Lens: Competitive Position and Growth Drivers

Haleon, established as a distinct entity following its spin-off from GSK, represents a formidable force in the consumer health sector. Its portfolio, anchored by the globally recognised Centrum multivitamin brand, illustrates the power of established trust and extensive retail distribution. For the B2B supplement industry, Haleon's operations provide a critical benchmark for market penetration, brand longevity, and the strategic evolution of legacy products within a dynamic health landscape. Their scale dictates market trends and shapes consumer expectations for efficacy and accessibility.

Company Snapshot

Haleon plc, headquartered in Weybridge, UK, operates as a publicly listed consumer healthcare company. While precise revenue figures fluctuate annually, the company consistently reports multi-billion-pound turnover. Its extensive brand portfolio spans oral health, pain relief, respiratory health, digestive health, and vitamins, minerals, and supplements (VMS). Key VMS brands include Centrum, Caltrate, and Sensodyne (though primarily oral health, it influences broader health perception). Haleon products are distributed across over 100 markets globally, supported by a substantial global workforce. This vast reach underscores its position as a global leader in consumer health.

Strategic Position and Recent Moves

Haleon's strategy since its 2022 demerger has centred on optimising its established portfolio and driving growth through innovation in key categories. The company has focused on premiumisation and scientific substantiation for its core VMS brands like Centrum, introducing new formats and targeted formulations. For instance, recent launches have included Centrum Men 50+ and Centrum Women 50+ variants, alongside chewable and gummy options, aimed at expanding demographic appeal and consumption occasions. While large-scale acquisitions have been less frequent in the immediate post-spin-off period, Haleon has pursued strategic partnerships with retail giants to enhance shelf presence and digital engagement. The company has also invested in direct-to-consumer (DTC) channels, leveraging its brand equity to build subscription models and personalised offerings, particularly in the US and UK markets. These moves demonstrate a clear intent to protect and grow market share in mature categories while adapting to evolving consumer purchasing habits.

What Manufacturers Can Learn

Haleon's approach offers several crucial lessons for contract manufacturers and ingredient suppliers. Their sustained investment in brand recognition for Centrum, despite it being a long-standing product, highlights the enduring value of trust and heritage. This suggests that even in a market increasingly fragmented by niche brands, a strong, well-marketed core product can maintain dominance. Furthermore, their focus on diverse delivery formats and age-specific formulations indicates a market trend towards convenience and tailored nutrition. In our experience manufacturing for clients at Supplement Factory, we observe a similar demand for innovative formats and bespoke blends. Brands are increasingly seeking partners who can deliver a broad range of options, from traditional capsules to advanced gummies and liquid formats. Haleon's strategy also underscores the importance of robust supply chain management at scale, ensuring consistent quality and availability across diverse global markets.

Risks and Headwinds

Despite its dominant position, Haleon faces several significant risks. The VMS market is intensely competitive, with a proliferation of smaller, agile brands that can quickly respond to emerging trends and offer highly specialised products. Regulatory scrutiny across global markets remains a constant challenge, particularly regarding health claims and ingredient sourcing. Furthermore, the rising cost of raw materials and logistics can impact profitability, especially for high-volume, lower-margin products. Reputational risks, linked to product efficacy or manufacturing standards, are also ever-present for a company of Haleon's scale. The ongoing consumer shift towards more natural, plant-based, and sustainably sourced ingredients also presents a challenge, requiring Haleon to adapt its vast, established supply chains and product lines to meet these evolving demands.

The B2B Verdict

Supplement businesses should certainly watch Haleon closely. Its retail leverage and brand power mean it sets benchmarks for consumer expectations and market access. For contract manufacturers, understanding Haleon's product innovation and supply chain demands can inform strategic capabilities development. Competing directly on price with mass-market multivitamins is challenging, but partnering on niche, premium, or innovative delivery formats could be viable. Ultimately, Haleon's trajectory illustrates the enduring power of a strong brand and extensive distribution, providing a valuable case study for any business operating within the consumer health sector.